Miami Cancer Institute to host inaugural Precision Oncology Symposium
Miami Cancer Institute, part of Baptist Health, announced it is hosting its inaugural Precision Oncology Symposium February 3-4, 2023, at the Biltmore Hotel in Coral Gables, Florida. The educational symposium is designed to provide an overview about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcoma and brain tumors — with novel targeted agents and treatment combinations.
“We… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 1, 2023 Category: American Health Authors: Baptist Health Source Type: news
Adverse Events Linked to Better Survival With ICIs in Melanoma Adverse Events Linked to Better Survival With ICIs in Melanoma
With immune checkpoint inhibitors (ICIs), survival is improved even among patients who develop higher-grade immune adverse events leading to hospitalization, a new study reveals.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Artificial DNA kills cancer
Researchers at the University of Tokyo have used artificial DNA to target and kill cancer cells in a completely new way. The method was effective in lab tests against human cervical cancer- and breast cancer-derived cells, and against malignant melanoma cells from mice. The team created a pair of chemically synthesized, hairpin-shaped, cancer-killing DNA. (Source: World Pharma News)
Source: World Pharma News - December 21, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Is Moderna Stock A Buy On A Bullish Update For Its Cancer Vaccine?
Moderna stock has surged past a buy point after unveiling promising midstage test results for its personalized cancer vaccine in melanoma patients. X Patients who received the Moderna (MRNA) cancer vaccine in addition to Merck's (MRK) Keytruda were 44% less likely to relapse or die compared with…#covidvaccine #mrna #bntx #afundamentallookat #marketsmithcom #pfizer #phase3 #pfe #gettimelybuysell #importantly (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2022 Category: Consumer Health News Source Type: news
Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanoma
(MedPage Today) -- Combination targeted therapy significantly improved 5-year progression-free survival (PFS) and overall survival (OS) versus single-agent vemurafenib (Zelboraf) and was numerically superior to single-agent encorafenib (Braftovi... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 19, 2022 Category: Dermatology Source Type: news
PET reveals risk of cardiovascular events in pneumonia patient
FDG-PET/CT scans have shown that vascular inflammation may be a trigger fo...Read more on AuntMinnie.comRelated Reading:
PET links adipose fat to breast cancer relapse
F-18 FDG lymph node uptake assessed in vaccinated COVID-19 patients
AI increases PET/CT reporting efficiency in lymphoma staging
PET/CT bests ultrasound for imaging malignant melanoma
PET/CT scans predict low thyroid function in radiotherapy patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 19, 2022 Category: Radiology Source Type: news
Fast acquisition techniques cut SPECT/CT bone scan times by half
Whole-body SPECT/CT bone scan times to detect metastatic tumors in prostat...Read more on AuntMinnie.comRelated Reading:
SPECT/CT AI model predicts major adverse cardiac events
SPECT tracers go head-to-head in prostate cancer patients
SPECT/CT proves value over CT diagnosing renal cancer
SPECT/CT augmented reality may help visualize metastatic melanoma
AI can detect metastatic bone lesions on scintigraphy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 19, 2022 Category: Radiology Source Type: news
Are These Multibillion-Dollar Vaccine Stocks Still a Buy?
Pharmaceutical companies Moderna (MRNA -6.74%) and Merck (MRK -0.39%) saw their shares rise 19.6% and 1.7%, respectively, on Tuesday after they announced impressive early results from their mRNA cancer vaccine to prevent melanoma, the deadliest form of skin cancer. Both companies' shares continued…#mrna #keytruda #talimogene #stellar #acceleronpharma #sotatercept #btk #melanomaresearchfoundation #mrk #pah (Source: Reuters: Health)
Source: Reuters: Health - December 18, 2022 Category: Consumer Health News Source Type: news
Killing pancreatic cancer with T cells that supercharge themselves
Scientists at UC San Francisco (UCSF) have engineered T cells to produce a potent anti-cancer cytokine, but only when they encounter tumor cells. The immunotherapy eliminated melanoma and pancreatic cancer in mice without major side effects, and it offers a promising new strategy for fighting these and other hard-to-treat cancers. (Source: World Pharma News)
Source: World Pharma News - December 16, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Whole-body PET/CT cuts scan time in melanoma patients
Whole-body PET/CT scans could reduce radiation dose and significantly trim imagin...Read more on AuntMinnie.comRelated Reading:
Whole-body PET/CT for a child: 5 minutes, no sedation
New PET/CT scanners may offer safer imaging in children
AI software could help cut PET scan times in half
PET/CT reveals heart artery inflammation in COVID-19 patients
PET/CT predicts treatment outcomes in myeloma patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2022 Category: Radiology Source Type: news
New mRNA Cancer Vaccine Passes Important Human Trial
An experimental mRNA cancer-fighting vaccine jointly developed by Moderna and Merck has reportedly succeeded in a Phase II trial. According to the companies, melanoma survivors who received the vaccine in combination with immunotherapy were 44% less likely to have their cancer return or to die…#mrna #phaseii #merckskeytruda #keytruda #modernaandmerck #mrna4157v940 #moderna #hpv #stéphanebancel #merck (Source: Reuters: Health)
Source: Reuters: Health - December 14, 2022 Category: Consumer Health News Source Type: news
Moderna, Merck Report on Promising Melanoma Vaccine
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 14, 2022 Category: Cancer & Oncology Tags: Infections, Oncology, News, Source Type: news
Experimental mRNA cancer vaccine with immunotherapy reduces risk of melanoma returning, preliminary study finds
An experimental personalized mRNA vaccine in combination with the immunotherapy Keytruda reduced the risk of recurrence or death from melanoma in patients who had already had surgery, Moderna and Merck said Tuesday. (Source: CNN.com - Health)
Source: CNN.com - Health - December 13, 2022 Category: Consumer Health News Source Type: news
Moderna, Merck Report on Promising Melanoma Vaccine
TUESDAY, Dec. 13, 2022 -- Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma.
Moderna, well known for its work on the COVID-19 vaccine, and Merck, which makes the cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2022 Category: Pharmaceuticals Source Type: news
Hopes For Melanoma Vaccine
TUESDAY, Dec. 13, 2022 -- Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma.
Moderna, well known for its work on the COVID-19 vaccine, and Merck, which makes the cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2022 Category: Pharmaceuticals Source Type: news
